CashuHua Medicine Launches Glucokinase Activator MYHOMSIS® for Type 2 Diabetes in Hong Kong16 days ago
CashuHua Medicine’s MYHOMSIS® Approval: Transforming Diabetes Treatment in Hong Kong and Beyond18 days ago
prnewswire.comHua Medicine Announces the Approval of Dorzagliatin for Marketing in Hong Kong SAR, China16 days ago
prnewswire.comNew State Capital Partners Launches Forge Select, Adds Sanjay Gupta to Lead Non-Control Investment Strategyabout 2 months ago
prnewswire.comDigiFT Introduces First Actively Managed Tokenized Equity Fund with BNY as Investment Management Services Providerabout 2 months ago
prnewswire.comHivemind Capital and CPIC Investment Management Announce Strategic Partnership to Establish $500 Million Real-World Asset Tokenization Fundabout 2 months ago
prnewswire.comGlobal Investment Casting Market Expected to Reach USD 32.3 Billion By 2035, Supported By Aerospace Dominance, Light weighting Trends, And Digital Foundry Transformationabout 2 months ago
prnewswire.comIntegrity Wealth and Humilis Investment Strategies Announce First U.S. SMA Partnershipabout 2 months ago
prnewswire.comRBC recommends shareholders reject TRC Capital Investment's below-market "mini tender" offer for common sharesabout 2 months ago
prnewswire.comExxat Receives Strategic Investment from Accel-KKR to Accelerate Growth and Innovationabout 2 months ago
prnewswire.comFlexTecs Announces Strategic Investment from Cohere Capital to Support Services Expansion, Technology Innovation, and Accelerate Growthabout 2 months ago